Intracerebral hemorrhage (ICH) holds a particularly prominent place in this year’s programme, with dedicated sessions, clinical trials, and innovative approaches spanning imaging, pathophysiology, and brain repair.
This is a crucial recognition for a condition that still too often lacks disease‑specific therapeutic solutions.

The TIPITCH RHU is proud to actively contribute to this momentum, with numerous presentations delivered by members of the consortium:
🔹 Prof. Charlotte Cordonnier (CHU de Lille)
• ESOC TV – Large Clinical Trials: implications for clinical practice
• Microcirculatory dysfunction in intracerebral hemorrhage
🔹 Dr Laurent Puy (Lille University Hospital)
• Can we stimulate haematoma clearance and repair mechanisms after ICH?
🔹 Dr Quentin Beaufort (PhD, Tours University Hospital)
• Non‑invasive exclusion of arteriovenous shunts in ICH using MRI arterial spin labelling
🔹 Prof. Marco Pasi (CHRU de Tours)
• Clinical relevance of cerebral amyloid angiopathy in acute stroke reperfusion therapies
🔹 Dr Valentin Amar (PhD, Tours University Hospital)
• Poster – Cognitive and neuroimaging profile of sporadic cerebral amyloid angiopathy patients with phosphorylated TAU positivity

Ahead of the main congress, the ICH Academy Meeting will take place on May 5, an international scientific event dedicated to ICH research, featuring contributions from Dr Valentin Amar, Dr Maxime Baudouin, and Dr Quentin Beaufort, PhD candidates within the TIPITCH project.

Thank you to the European Stroke Organisation for the prominent place given to ICH at ESOC 2026, and congratulations to all clinician‑scientists committed to advancing research in this still underexplored field.